146 related articles for article (PubMed ID: 35339044)
1. Expression analysis of IFNAR1 and TYK2 transcripts in COVID-19 patients.
Akbari M; Akhavan-Bahabadi M; Shafigh N; Taheriazam A; Hussen BM; Sayad A; Fathi M; Taheri M; Ghafouri-Fard S; Fathi M
Cytokine; 2022 May; 153():155849. PubMed ID: 35339044
[TBL] [Abstract][Full Text] [Related]
2. Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2.
Piganis RA; De Weerd NA; Gould JA; Schindler CW; Mansell A; Nicholson SE; Hertzog PJ
J Biol Chem; 2011 Sep; 286(39):33811-8. PubMed ID: 21757742
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of IFNAR2 and TYK2 transcripts' prognostic role in COVID-19 patients: a retrospective study.
Razavi A; Raei M; Hatami Y; Chokami GS; Goudarzi Y; Ghasemian R; Alizadeh-Navaei R; Yarmohammadi H; Soltanipur M; Tabarestani M; Valadan R; Meshkinfam Haghighi F; Tarsi AK; Razavi B
Front Cell Infect Microbiol; 2024; 14():1356542. PubMed ID: 38741892
[TBL] [Abstract][Full Text] [Related]
4. Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif.
Kumar KG; Varghese B; Banerjee A; Baker DP; Constantinescu SN; Pellegrini S; Fuchs SY
J Biol Chem; 2008 Jul; 283(27):18566-72. PubMed ID: 18474601
[TBL] [Abstract][Full Text] [Related]
5. Organ-specific and differential requirement of TYK2 and IFNAR1 for LPS-induced iNOS expression in vivo.
Painz R; Walter I; Kolbe T; Rigler D; Vogl C; Steinborn R; Rülicke T; Helmreich M; Karaghiosoff M; Müller M
Immunobiology; 2007; 212(9-10):863-75. PubMed ID: 18086385
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 Disrupts Proximal Elements in the JAK-STAT Pathway.
Chen DY; Khan N; Close BJ; Goel RK; Blum B; Tavares AH; Kenney D; Conway HL; Ewoldt JK; Chitalia VC; Crossland NA; Chen CS; Kotton DN; Baker SC; Fuchs SY; Connor JH; Douam F; Emili A; Saeed M
J Virol; 2021 Sep; 95(19):e0086221. PubMed ID: 34260266
[TBL] [Abstract][Full Text] [Related]
7. The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.
Ragimbeau J; Dondi E; Alcover A; Eid P; Uzé G; Pellegrini S
EMBO J; 2003 Feb; 22(3):537-47. PubMed ID: 12554654
[TBL] [Abstract][Full Text] [Related]
8. Specific contribution of Tyk2 JH regions to the binding and the expression of the interferon alpha/beta receptor component IFNAR1.
Richter MF; Duménil G; Uzé G; Fellous M; Pellegrini S
J Biol Chem; 1998 Sep; 273(38):24723-9. PubMed ID: 9733772
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B virus X protein inhibits extracellular IFN-α-mediated signal transduction by downregulation of type I IFN receptor.
Cho IR; Oh M; Koh SS; Malilas W; Srisuttee R; Jhun BH; Pellegrini S; Fuchs SY; Chung YH
Int J Mol Med; 2012 Apr; 29(4):581-6. PubMed ID: 22218495
[TBL] [Abstract][Full Text] [Related]
10. Type I IFN receptor controls activated TYK2 in the nucleus: implications for EAE therapy.
Ahmed CM; Noon-Song EN; Kemppainen K; Pascalli MP; Johnson HM
J Neuroimmunol; 2013 Jan; 254(1-2):101-9. PubMed ID: 23110939
[TBL] [Abstract][Full Text] [Related]
11. TYK2, IFITM3, IFNAR2 and OAS3 single-nucleotide polymorphisms among severe COVID-19 ICU patients in Morocco.
Benmansour R; Tagajdid MR; El Hamzaoui H; Fjouji S; Doghmi N; Houba A; Belbacha I; Elkochri S; Aabi R; Elannaz H; Laraqui A; El Mchichi B; Chmitah T; Touil N; Ennibi K; Eljaoudi R; Elmir E; Amine Lahlou I; Oumzil H
Int J Immunopathol Pharmacol; 2024; 38():3946320241257241. PubMed ID: 38760017
[TBL] [Abstract][Full Text] [Related]
12. Molecular characterization of an alpha interferon receptor 1 subunit (IFNaR1) domain required for TYK2 binding and signal transduction.
Yan H; Krishnan K; Lim JT; Contillo LG; Krolewski JJ
Mol Cell Biol; 1996 May; 16(5):2074-82. PubMed ID: 8628273
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine kinase 2 promotes sepsis-associated lethality by facilitating production of interleukin-27.
Bosmann M; Strobl B; Kichler N; Rigler D; Grailer JJ; Pache F; Murray PJ; Müller M; Ward PA
J Leukoc Biol; 2014 Jul; 96(1):123-31. PubMed ID: 24604832
[TBL] [Abstract][Full Text] [Related]
14. The amino-terminal region of Tyk2 sustains the level of interferon alpha receptor 1, a component of the interferon alpha/beta receptor.
Gauzzi MC; Barbieri G; Richter MF; Uzé G; Ling L; Fellous M; Pellegrini S
Proc Natl Acad Sci U S A; 1997 Oct; 94(22):11839-44. PubMed ID: 9342324
[TBL] [Abstract][Full Text] [Related]
15. TYK2 Variants in B-Acute Lymphoblastic Leukaemia.
Turrubiartes-Martínez E; Bodega-Mayor I; Delgado-Wicke P; Molina-Jiménez F; Casique-Aguirre D; González-Andrade M; Rapado I; Camós M; Díaz-de-Heredia C; Barragán E; Ramírez-Orellana M; Aguado B; Figuera Á; Martínez-López J; Fernández-Ruiz E
Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33260630
[TBL] [Abstract][Full Text] [Related]
16. Identification of an indispensable role for tyrosine kinase 2 in CTL-mediated tumor surveillance.
Simma O; Zebedin E; Neugebauer N; Schellack C; Pilz A; Chang-Rodriguez S; Lingnau K; Weisz E; Putz EM; Pickl WF; Felzmann T; Müller M; Decker T; Sexl V; Stoiber D
Cancer Res; 2009 Jan; 69(1):203-11. PubMed ID: 19118004
[TBL] [Abstract][Full Text] [Related]
17. Tyrosine phosphorylation of protein kinase D2 mediates ligand-inducible elimination of the Type 1 interferon receptor.
Zheng H; Qian J; Baker DP; Fuchs SY
J Biol Chem; 2011 Oct; 286(41):35733-35741. PubMed ID: 21865166
[TBL] [Abstract][Full Text] [Related]
18. TYK2 activity promotes ligand-induced IFNAR1 proteolysis.
Marijanovic Z; Ragimbeau J; Kumar KG; Fuchs SY; Pellegrini S
Biochem J; 2006 Jul; 397(1):31-8. PubMed ID: 16551269
[TBL] [Abstract][Full Text] [Related]
19. TYK2 single-nucleotide variants associated with the severity of COVID-19 disease.
Zabihi Rizi F; Ghorbani A; Zahtab P; Darbaghshahi NN; Ataee N; Pourhamzeh P; Hamzei B; Dolatabadi NF; Zamani A; Hooshmand M
Arch Virol; 2023 Mar; 168(4):119. PubMed ID: 36959416
[TBL] [Abstract][Full Text] [Related]
20. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared Jak kinase.
Dondi E; Pattyn E; Lutfalla G; Van Ostade X; Uzé G; Pellegrini S; Tavernier J
J Biol Chem; 2001 Dec; 276(50):47004-12. PubMed ID: 11602573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
